Situated in southwest France in the Aquitaine region, the innovative cluster “Prod’Innov” specializes in Agri-Food, Nutrition, Health and Medicine.
The cluster’s objective is to create a synergistic environment favorable to the development of innovative products and processes for nutrition and health through the production of new medicine and foods and the anticipation of health and safety quality requirements.
This objective involves many factors:
Wealth creation Creation of jobs Innovation Industrial development
Regional development Attractiveness Creation of businesses Emergence of new participants
Advantages
The cluster has a privileged place in its sector of activity in the country
Agri-Food, Nutrition and Health sectors in Aquitaine
Companies and Jobs
40,000 industrial jobs
Over 600 companies
Research
1,500 researchers, 300 PhD students
130 university laboratories
Training
4 universities
4 engineering schools
Training from Bac to Bac+11
Members
Over 110 members
Companies: 77
• French companies: Air Liquide, Sanofi-Aventis, Labeyrie, Pierre Fabre, Bonduelle, Total, Syngenta Seeds, Bertin, Bongrain etc.
• International companies: Bristol-Myers Squibb (United States), B. Braun Melsungen (Germany), Monsanto (United States), Lindt&Sprungli (Switzerland), Lu, subsidiary of Kraft Foods (United States), Altadis (France-Spain) etc.
• 50 small-and-medium-sized enterprises (SME): Tournay biotechnologies, Biolandes, Berkem, Saf Isis, Galenix, Inflamed, Mitoprod, Vitamont, Vitagermine etc.
Research and Educational Institutions
20 centers, including the Institut National de la Recherche Agronomique (INRA), Institut National Français de Recherche pour l’Exploitation de la Mer (IFREMER), Université de Bordeaux Sciences et Technologies, Université de Bordeaux Victor Segalen, Institut européen de Chimie et Biologie, Institut de Santé Publique, d’Epidémiologie et de Développement, Institut des Sciences de la Vigne et du Vin, Université de Pau et du Pays de l’Adour etc.
Almost 20 other organizations are also partners of the cluster, including Bordeaux Montesquieu, Incubateur Régional d’Aquitaine, Innovalis Aquitaine, Agropole d’Agen, Regional Council of Aquitaine etc.
Current R&D Partnerships (refer to appendix)
36 projects have been certified and financed as at the end of 2007, for a total amount of € 56 million and public subsidies at the level of € 18 million
Public support examples:
• 8 million euros granted by the National Research Agency (Agence Nationale de la Recherche or ANR) between 2005 and 2007
• € 6.5 million provided by the Regional Council of Aquitaine
• Over 2 million euros allocated by the Single Interministerial Fund (Fonds Unique Interministériel or FUI) in the same period
• € 1.5 million granted by OSEO
International Partnerships
Current
- French-Canadian Scientific Symposium in Quebec in May 2008
- Participation in Bio Boston, United States
-Participation in Vitafoods International exhibition, Switzerland
- And in Eurobio convention, Paris
Future
- Business mission to the Basque region in November 2008
- “Health” export missions with the CCI: Japan/Korea and Singapore/Australia
- Participation in the Health Ingredients Europe show in Paris
Appendix: Selected certified R&D Projects
|
Project Name and Subject |
Led by |
|
NEOTOK: Process for production and preservation of vaccines against infectious diseases |
CEVA Santé Animale, Vitamfero, Total Budget: € 4,582,000 |
|
PRUN’ACTIVE: Role of dried fruits in the prevention of chronic diseases |
Maître Prunille, Berkem, BIP, Nutratech Conseils, INRA Theix, Polyphénols Biotech ( Total Budget: € 3,301,154 |
|
PROBISIS: Therapeutic probiotics against chronic intestinal inflammatory diseases |
Saf Isis, Ellipse Pharmaceuticals, Florus, ENITA Bordeaux, INRA Toulouse Total Budget: € 3,650,038 |
|
PHY510: Topical delivery of ciclosporine |
Physica Pharma, Orkeo, Nantes School of Veterinary medicine Total Budget: € 1,682,790 |
|
RNAgenix: Development, delivery and production of an RNA drug against Hepatitis C |
Flamel Technologies, Mitoprod, Total Budget: € 2,933,264 |
|
PARAVEC: Nanoparticles for trypanosomes targeting |
CEVA Santé Animale, DBI, Inflamed, Total Budget: € 3,974,141 |
|
COGINUT: Fatty Acids, Antioxidants, and Cognitive Function: Nutritional factors in cerebral aging |
University of Bordeaux 2, University of Bordeaux 1, University of Montpellier, DSM Nutritional Products, ITERG, laboratoires ESAI, Lesieur, Sanofi-Aventis Total Budget: € 1,940,000 |
|
ELLAG’INNOV: Synthesis and anti-tumoral effect of natural polyphenols (C-aryl glycosidic ellagitannins) and of their analogs |
IECB Université Bordeaux 1, Fluofarma, Superfluid, INSERM E347. Total Budget: € 1,902,692 |
|
MONIMAIZE: The fusarium "Gibberella fujikoroi" complex on maize: New insights on pathogen/pathogen and host/pathogen interactions and their consequences on fumonisin biosynthesis |
MycSA UR 1264 INRA Bordeaux, Biogemma, Biotransfer Total Budget: € 1,057,668 |
A major structuring project: Industrial Biodevelopment Park
- A 10,000m² cluster of laboratories, pilot production workshops (GMP) and administrative offices
- 7 companies involved
Objectives:
• Cost-effective shared resources and equipment
• Cluster together pharmaceutical and biotech companies at all stages of their growth
• Enhance scientific public/private partnerships
• Promote these companies and their local partners
Budget: € 25 million; Public Funding: € 313,619
- More information on Prod'Innov
Contact
Invest in France Agency Paris
Laurent BERGEOT
Director, Territories Development
Send an e-mail
+33 1 40 74 74 11






